Chu Yu-Waye 4
4 · FATE THERAPEUTICS INC · Filed Apr 21, 2022
Insider Transaction Report
Form 4
Chu Yu-Waye
Senior VP Clinical Development
Transactions
- Sale
Common Stock
2022-04-19$35.37/sh−4,062$143,673→ 151,033 total
Footnotes (2)
- [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Represents the weighted average sale price of the shares sold from $35.10 to $35.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2.